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Psychological Stress and Other Potential Triggers for 
Recurrences of Herpes Simplex Virus Eye Infections 
Herpetic Eye Disease Study Group 
Obiectlve:  To assess psychological stress and other fac-
tors as possible triggers of ocular herpes simplex virus 
(HSY) recurrences. 
in which the exposure week log was completed late af-
ter the onset of symptoms. 
Design: A prospective cohort study nested in a random-
ized, placebo-controlled, clinical trial. 
Results: Thirty-three participants experienced a study out-
come meeting these criteria. Higher levels of psychologi-
cal stress were not associated with an increased risk of 
recurrence (rate ratio, 0.58; 95% confidence interval, 0.32-
1.05; P=.07). No association was found between any of 
the other exposure variables and recurrence. When an 
analysis was performed including only the recurrences 
(n=26) for which the exposure week log was completed 
late and after symptom onset, there was a clear indication 
of retrospective overreporting of high stress (P = .03) and 
systemic infection (P= .01). Not excluding these cases could 
have produced incorrect conclusions due to recall bias. 
S e t t i n g :  Fifty-eight community-based or university 
sites. 
Participants: lmmunocompetent adults (N = 308), aged 
18 years or older, with a documented history of ocular 
HSY disease in the prior year and observed for up to 15 
months. 
Exposure Varlables :  Psychological stress, systemic in-
fection, sunlight exposure, menstrual period, contact lens 
wear, and eye injury recorded on a weekly log. The ex-
posure period was considered to be the week before symp-
tomatic onset of a recurrence. 
Concluslons: Psychological stress does not appear to be 
a trigger of recurrences of ocular HSY disease. If not ac-
counted for, recall bias can substantially overestimate the 
importance of factors that do not have a causal associa-
tion with HSY infection. 
Main Outcome Measure :  The first documented re-
currence of ocular HSY disease, with exclusion of cases Arch Ophthalmol. 2000;118:1617-1625 
A complete list of the members 
of the Herpetic Eye Disease 
Study Group appears in a box 
on page 1624. None of the 
authors has a proprietary 
interest in any of the drugs 
used in this study. 
H ERPESSIMPLEXvirus (HSY) is a leading cause of eye infections and visual  loss. 1 •2 An important con-tributor to visual loss from 
HSY infection is its recurring nature. Sev-
eral factors have been suggested as poten-
For editorial comment 
see page 1682 
tial triggers of recurrent ocular, orofacial, 
or genital HSY disease, including upper res-
piratory tract infection,3•4 fever, 5•6 sun-
light,7·8 seasonal conditions,3•9 -11 emo-
tional factors, 1 2-1 5 psychological stress, 14•1 6 •1 9 
trauma,20 and menstruation. 2 1 However, re-
sults from these studies have been incon-
sistent, and only a few studies have as-
sessed ocular HSY recurrences. 
In a randomized, placebo-con-
trolled, clinical trial, we found that 12 
months of oral acyclovir therapy was ben-
eficial in reducing the incidence of ocular 
HSY recurrences in participants with a re-
cent history of active ocular HSY disease. 
In both treatment groups, the number of 
prior episodes of HSY eye disease was the 
only baseline or historical factor that was 
a strong predictor of a recurrence. 22 Herein, 
we report the results of a prospective co-
hort study, nested within this clinical trial, 
that assessed psychological stress and other 




All 308 participants had experienced at 
least 1 prior ocular HSY disease episode 
(as per eligibility requirements); 50% had 
experienced 3 or more episodes (Table I ) . 
When compared with the 229 patients in 
PARTICIPANTS AND METHODS 
An institutional review board approved the study pro-
tocol and informed consent forms for each site, and an 
independent Data Safety and Monitoring Committee 
provided study oversight. 
PARTICIPANTS 
To be eligible for the treatment trial, a participant must have 
experienced active HSY eye disease within the previous 12 
months that was inactive and untreated for at least 30 days 
before trial enrollment. In the treatment trial, participants re-
ceived either oral acyclovir or placebo for 12 months and then 
were observed for 6 months while not receiving treatment. 22 
Additional eligibility criteria for this recurrence fac-
tors study cohort included the following: (1) age 18 years 
or older, (2) 10th grade or greater educational level, and 
(3) ability to read and write English. Eligible participants
were asked to enroll in the recurrence factors study by the 
end of the first month of the treatment trial but could be
enrolled as late as 9 months into the trial. The median time 
from enrollment into the treatment trial to enrollment in
the recurrence factors study was 3 weeks (25th percentile,
10 days; and 75th percentile, 4 weeks). Data collection for 
the recurrence factors study ended when the participant
had completed 15 months of the treatment trial. 
Fifty-eight of the 7 4 clinical sites involved in the treat-
ment trial participated in the recurrence factors study. At these 
sites, among the 565 participants enrolled in the treatment 
trial who were also eligible for the recurrence factors study, 
336 (60%) agreed to participate. Participants were excluded 
from analysis if they developed active HSY eye disease ei-
ther before enrollment into the recurrence factors study (n = 7) 
or shortly after study enrollment such that either a symptom-
onset date could not be determined or a weekly log for the 
exposure week was not available (n = 5). Also excluded were 
15 participants who completed baseline information only and 
dropped out before submitting any subse quent logs and 1 par-
ticipant who was subsequently deemed to be ineligible for 
the treatment trial. These exclusions left a sample of 308 for 
analysis. Among the 308 patients, 155 were in the acyclovir 
group and 153 were in the placebo group. 
BASELINE DATA COLLECTION 
In addition to the data available from the treatment trial, data 
were obtained on occupation, income, living situation, and the 
psychological constructs of negative affectivity and social de-
sirability. Negative affectivity, defined as the disposition to ex-
perience aversive emotional states, 23 was assessed by use of a
20-item version of the Taylor Manifest Anxiety Scale. This in-
strument has been shown to correlate highly with the full Tay-
lor Manifest Anxiety Scale (Pearson r = 0.91) and to exhibit ad-
equate reliability ( Cronbach a=. 7 6). 24 Social desirability was
assessed with a 20-item version of the Marlowe-Crowne So-
cial Desirability Scale, which taps defensiveness and the ten-
dency to show a positively biased self-image. 25.26 The short form 
has shown adequate reliability (Pearson r = 0. 73-0.87).27 
the treatment trial who were eligible for but did not en-
roll in the recurrence factors study, the 308 participants 
were more likely to be white (85% vs 71 %; P<.001), but 
were similar in sex, age, and number of past episodes of 
WEEKLY DATA COLLECTION 
Participants completed a log at home once a week (for most 
participants, each Sunday) on which they reported expe-
riences during the prior 7 days. This included rating their 
psychological stress and reporting on illnesses, sun expo-
sure, contact lens wear, eye injury, and the onset of a men-
strual period. The "weekly logs" were mailed directly to 
the Data Coordinating Center. 
Logs were considered valid only if they were com-
pleted no more than 2 days before and no more than 6 days 
after the end of the log week.  In addition, for logs com-
pleted for the exposure week of participants with a recur-
rence (as defined later), the log was considered invalid if 
the completion date was on or after the date of onset of symp-
toms of a confirmed recurrence. Only data from logs deemed 
to be valid were included in the primary analysis. 
Psychological Stress 
The weekly log included 3 measures of stress: a global stress 
rating scale, an open-ended question about chronic stress 
(asking participants to describe situations that had been 
stressful for ≥2 weeks), and the Life Arenas Stress Mea-
sure. Our primary stress measure was the global stress rat-
ing scale, which consisted of a single question: "Overall, 
how stressed have you felt this past week?," with a 1 to 7 
Likert-type rating scale for responses. For the primary analy-
sis, we collapsed these 7 levels into 3 levels according to 
the response labels "not at all," which appeared above 1 to 
2; "moderately," which appeared above 3 to 5; and "ex-
tremely," which appeared above 6 to 7. An average stress 
level across the study was calculated from the global stress 
rating across all logs for participants submitting at least 5 
valid logs (excluding the exposure week for participants 
with a recurrence). The presence of chronic stress was as-
sessed in analyses as a weekly indicator variable. 
The Life Arenas Stress Measure consisted of a similar 
7-point scale on which participants rated stressfulness in 11 
areas of daily life: health; financial; home situation; personal 
goals; relationships outside the home; and if applicable, re-
lationships inside the home; problems with friends and fam-
ily; school-related stress; work-related stress; unemployment-
related stress; and retirement-related stress. The Life Arenas 
Stress Measure was assessed previously for construct valid-
ity, via a correlation with a global measure of stress (r = 0.56), 
and convergent validity, as indicated by hy p othesized posi-
tive correlations between specific life arena stress scores and 
corresponding stress arena scores derived from log-based 
stressor descriptions and ratings (F. C., unpublished data, No-
vember 1996). Two variables derived from the Life Arenas 
Stress Measure were used in secondary analyses: the sum of 
the first 5 life arenas previously listed plus the work-related 
arena (life arenas sum) and the maximum rating among all 
11 life arenas (maximum stress). These 2 measures derived 
from the Life Arenas Stress Measure were highly correlated 
with the global stress rating scale (Spearman rank correla-
tion coefficient [r,] = 0.84 and 0.89, respectively), and were 
also highly correlated with each other (r, = 0.85).
HSY eye disease. The baseline characteristics of the 238 
participants enrolled within 4 weeks of enrollment into 
the treatment trial were similar to those of the 70 par-
ticipants enrolled later. 
Other Variables 
Self-reported symptoms suggestive of an infectious sy ndrome 
were assessed by a checklist and an "other illness" write-in 
response ( to be referred to as "systemic illness"). Illness was 
considered to have been present when one of the following 
was checked as being present-cold or respiratory tract in-
fection; stomach flu, vomiting, or diarrhea; or fever--or when 
participants wrote in names of illnesses suggestive of a sys-
temic bacterial or viral infection ( eg, hepatitis or pneumonia). 
Unprotected sunlight exposure was assessed by the par-
ticipant's response to the question, "In the past week, ap-
proximately how many total hours did you spend out-
doors unprotected by a brimmed hat or other protective 
clothing?" Respondents selected from one of the follow-
ing categories: 0 to 7, 8 to 14, 15 to 21, 22 to 28, or 29 or 
more hours. For analysis, the 5 categories were collapsed 
into 2: 0 to 21 and 22 or more hours. 
Participants also were queried on each weekly log via 
yes/no questions as to: (1) the occurrence of an eye injury; 
(2) the use of contact lenses; and (3) for premenopausal
women, whether the menstrual period began in the last 7
days. The menstrual cycle analysis included only the 64
women younger than 50 years reporting at least 1 men-
strual cycle during follow-up.
OUTCOME 
The study outcome was defined as the first recurrence of 
active HSV eye disease in any form (blepharitis, conjunc-
tivitis, epithelial keratitis, stromal keratitis, and/or irido-
cyclitis) confirmed on examination by a certified study oph-
thalmologist using slitlamp biomicroscopy. Clinical 
examinations were performed after treatment trial months 
1, 3, 6, 9, 12, 13, and 15 and at additional times when a 
participant reported new ocular symptoms. Recurrences 
were dated at the onset of participant symptoms, as de-
scribed later. For the primary analysis, only recurrences as-
sociated with a valid exposure week log were included. 
EXPOSURE PERIOD 
The symptom-onset date was determined from the earli-
est symptom onset reported on a valid weekly log from the 
4 weeks before the examination documenting the recur-
rence, from the study examination form, or from medical 
records completed on the date of the examination. When 
different symptom-onset dates were recorded on a valid 
weekly log and the examination form, the date recorded 
on the weekly log was used. For participants without symp-
tom-onset data from any of these sources, symptom onset 
was imputed to be 7 days before the documented recur-
rence. This imputation was based on the data available for 
the 59 participants with a documented recurrence who had 
a recorded symptom-onset date (45 [76%] had the onset 
of symptoms in the prior week). 
The exposure period for assessment of each time-
dependent variable was considered to be the week before 
symptom onset. Because exposure data were gathered 
weekly, the exposure period consisted of a 7-day period that 
The baseline global stress scores were positively cor-
related with the measure of negative affectivity (r5= 0. 40, 
P<.001) and inversely correlated with the measure of so-
cial desirability (r5= - 0.19, P = .002). The baseline scores 
varied in relationship to the date of symptom onset accord-
ing to the day of the week on which symptoms first devel-
oped. The exposure period thus ranged from the period 1 
to 7 days before symptom onset (eg, weekly log com-
pleted on Sunday and symptom onset occurred the next 
day on Monday) to the period 7 to 13 days before symp-
tom onset ( eg, weekly log completed on Sunday and symp-
tom onset occurred on the following Sunday). 
STATISTICAL ANALYSIS 
Comparisons between eligible nonenrolled participants and 
enrolled participants and between participants who com-
pleted follow-up and those who did not were made using
t tests, Wilcoxon rank sum tests, or x2 tests as appropri-
ate. Correlations between the different psychological stress 
measures were made using rs, treating follow-up weeks as 
independent observations. 
A discrete-time proportional hazards model28 fit by pooled 
logistic regression29 was used to assess the relationship between 
the exposure variables and an ocular HSV recurrence. The 
weekly measure of global psychological stress was specified 
as a time-dependent covariate. A change in psychological stress 
was modeled by evaluating the weekly global stress while con-
trolling for the participant's average stress across the study, 
thereby making a within-person assessment. Data for partici-
pants with incomplete follow-up were censored after the last 
weekly log received, and data for participants with invalid re-
currences (because of an invalid exposure week log, see pre-
vious information) were censored at the beginning of the ex-
posure week (the week that preceded the recurrence). 
The global stress variable was first assessed in a uni-
variate model and then in models adjusting for treatment 
group, self-reported illness, demographics, and other rel-
evant baseline variables. The univariate and full models are 
reported; 95% confidence intervals were computed for all 
measures. Models including subsets of the covariates pro-
duced similar results. Effect modification (interaction terms 
with an associated P <  .10 retained for further screening) and 
confounding (a change in the effect estimate b y >  10%30) were 
assessed. There was no evidence of interaction between the 
global stress variable and treatment group. Linear and cur-
vilinear effects were assessed by use of continuous vari-
ables and poly nomial effects, respectively. 
Available-case and complete-case methods of analysis 
with missing data were used for the univariate and multi-
variable analyses, respectively. 3 1•3 2 No appreciable differ-
ences were observed when analysis was restricted to partici-
pants with 80% or more weekly log completion. 
The chronic stress indicator variable, other exposure 
variables (systemic infection, sunlight exposure, contact lens 
use, and the onset of menses), and fixed trait characteris-
tics (negative affectivity and social desirability) were as-
sessed in similar discrete-time proportional hazards mod-
els as previously described. 
A case-crossover analysis3 3 also was performed. In the 
case-crossover analysis, in which data were limited to the 
33 participants with a valid recurrence, each participant 
Continued on next page 
were slightly higher than the scores from the follow-up 
logs (3.4± 1.8 vs 3.0± 1.6; P<.001) (Table 2) .  A par-
ticipant's weekly stress scores were strongly correlated 
with the participant's average stress for all weeks (r5= 0.81, 
becomes a separate stratum in a discrete-time propor-
tional hazards model, and the participant's mean stress 
level in the control period (the period before the ex-
posure period) is compared with the participant's stress 
in the exposure period (the week before symptom onset). 
Thus, the method assesses a within-person change in 
stress, while removing any possibility of between-
person confounding. 
Analyses were replicated using only recur-
rences with invalid exposure week logs (completed 
late after symptom onset). For this analysis, data from 
participants with valid recurrences were censored at 
the beginning of the exposure week log. 
Analyses were performed using statistical soft-
ware.34 All P values are 2-sided. Data are given as 
mean± SD unless otherwise indicated. 
The sample size for the recurrence factors study 
was a function of the treatment trial sample size. We 
estimated that there was 80% power (assuming a 
2-sided type I error rate of .05) to detect a rate ratio 
of recurrence of 2 or greater for moderate or high stress 
exposure (levels 3-7) compared with low stress (lev-
els 1-2) and 99% power to detect a rate ratio of 2.5 
or greater. This was based on an estimated recur-
rence rate of 14% related to low stress exposure. 
P<.001). The reporting on a weekly log of a chronic (≥2 
weeks) stressful situation was associated with a higher 
global stress score (4.0± 1.5 vs 2.4± 1.4; P<.001). 
COMPLETENESS OF FOLLOW-UP 
The study was completed (defined as the development of 
documented active HSV eye disease or completion of the 
15-month follow-up period) by 223 (72%) of the 308 par-
ticipants (Figure). For 16 of the 85 "noncompleters," early 
termination was related to termination from the treat-
ment trial, and for the other 69, termination was related 
to the participant's decision to stop completing the weekly 
logs. The median length of study completion for the non-
completers was 22 weeks (25th percentile, 8 weeks; and 
75th percentile, 47 weeks). The 223 "completers" were older 
(52± 15 vs 44± 16 years; P<.001) and more likely to be re-
tired (30% vs 14%; P=.009) than the 85 noncompleters. 
The log completion rate was 93% (10459 of 11213 
possible logs) for the 223 completers and 78% (1777 of 
2276 possible logs before termination) for the 85 non-
completers. Of the submitted logs, 10% were consid-
ered invalid (ie, completed > 2 days before or > 6  days 
after the end of the log week) for the completers and 16% 
for the noncompleters. 
RECURRENCES OF OCULAR HSV DISEASE 
A documented recurrence of ocular HSV disease devel-
oped in 67 (22%) of the 308 participants. Two of the 67 
participants did not submit a log for the exposure week (the 
week before symptom onset). Among the other 65 partici-
pants with a recurrence, the exposure week log was con-
sidered invalid for 30 (completed late, after symptom on-
Table 1. Characteristics of the 308 Participants* 
Characteristic 
Female sex 
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Taylor Manifest Anxiety Scale score, mean (SD)§ 




Spouse or partner 
Spouse or partner and children 




No. of past episodes of HSV eye disease, median 
(quartiles) 
Time from the last ocular HSV episode to the first 


























3 (1, 5) 
23 (13, 44) 
* There were missing data for income (n = 59), occupation (n = 37), the 
Taylor Manifest Anxiety Scale (n = 6), the Marlowe-Crowne Social Desirability 
Scale (n = 6), and living situation (n = 42). HSV indicates herpes simplex 
virus. 
† Unless otherwise indicated. Percentages may not total 100 because of 
rounding. 
‡lncluding student, homemaker, and unemployed. 
§A higher score represents higher anxiety (norm, 5.9).35 
IIA higher score represents higher social desirability (norm, 9.1; 
SD, 3.9).36 
set, in 26 cases and completed > 2 days early in 4). For the 
remaining 35 participants with a recurrence whose expo-
sure week log was valid, the symptom-onset date was de-
termined from the weekly logs for 10, from the ocular ex-
amination form for 18, and by imputation (see the 
"Exposure Period" subsection of the "Participants and Meth-
ods" section) for 7. Two participants with valid exposure 
week logs were missing the global stress score, which re-
duced the effective number of valid recurrences to 33 in 
the analyses of the global stress variable. 
ASSOCIATION OF PSYCHOLOGICAL STRESS 
AND OCULAR HSV RECURRENCE 
High global stress (when evaluated as a 3-level continu-
ous variable) was not associated with an increased risk of 
recurrence in the discrete-time proportional hazards model. 
Covariate adjustment provided no meaningful difference 
in the estimate of this association (Table 3). Similar re-











No. (%) of Participants 
Baseline Rating 








3.4 ± 1.8 
Follow-up 
Ratings 








3.0 ± 1.6 
Exposure 
Week Ratings 








2.5 ± 1.3 
* Includes valid logs only (see "Weekly Data Collection" subsection of  the 
"Participants and Methods" section for definition). Percentages may not total 
100 because of  rounding. 
sults were obtained when the global stress scores were ana-
lyzed as a 1 to 7 continuous variable and for the Life Are-
nas Stress Measure sum and maximum (data not shown). 
The mean of the average global stress scores (com-
puted across all weeks for participants with at least 5 valid 
logs) was 2.6 ± 1.1 in the 29 participants with a valid re-
currence (and a nonmissing exposure week stress score) 
and 3.1 ± 1.3 in the 221 who did not experience a recur-
rence (P=.06). Among these 29 participants with a valid 
recurrence, the exposure week stress score was similar 
to their average stress in all other weeks (2.5 ± 1.2 vs 
2.6±1.1; P=.20, paired t test), and the correlation be-
tween their exposure week stress scores and their aver-
age of the prior weeks was 0 .84. In accord with the weekly 
global stress measure, a high average stress score was not 
associated with increased risk of recurrence (unad-
justed rate ratio for a 1-SD increase in average stress, 0.74; 
95% confidence interval, 0 .50-1.10; P = .14). 
Also in accord with the other measures of stress, there 
was no indication of an association between an in-
creased risk of a recurrence and either a change in global 
stress (assessed in a model including the weekly global 
stress scores and average stress) (Table 3) or presence 
of a chronic (2:2 weeks) stressful situation (unadjusted 
rate ratio, 0.46; 95% confidence interval, 0.20-1.05; 
P=.07). There was also no association between recur-
rence and personality measures of negative affectivity ( un-
adjusted rate ratio for a 1-SD increase, 0.98; 95% confi-
dence interval, 0.70-1.38; P=.91) or social desirability 
( unadjusted rate ratio for a 1-SD increase, 0.92; 95% con-
fidence interval, 0.66-1.28; P=.61). 
Analyses of the global stress scores conducted us-
ing the case-crossover method, which limits the data to 
those participants who had a valid recurrence (n=33), 
produced results similar to those of the discrete-time pro-
portional hazards model (Table 4) .  
ASSOCIATION OF OTHER POTENTIAL TRIGGERS 
AND OCULAR HSV RECURRENCE 
During the study, a systemic infection was reported on 13% 
of the weekly logs, sun exposure of more than 21 hours in 
a week on 7%, and contact lens wear on 10%. None of these 
Enrolled 
(N=336) 







No Recurrence and 
Complete Follow-up 
(n=156) 






Invalid or Missing 
Exposure Week Log 
(n=32) 
Patient flowchart. For the 28 patients removed before analysis, a baseline log 
only was available tor 15, a preenrollment outcome occurred in 7, the 
exposure week was unattainable due to an early recurrence in 5, and 
ineligibility occurred in 1. HSV indicates herpes simplex virus. 
potential triggers were found to be associated with recur-
rences in either the discrete-time proportional hazards analy-
sis (Table S) or the case-crossover analysis ( data not shown). 
Among the 64 women younger than 50 years who 
reported at least 1 menstrual period during the study, there 
were only 7 valid recurrences. Although no association 
was found between the onset of the menstrual period and 
a recurrence, the study's power was too low for any mean-
ingful assessment. Similarly, eye injuries were reported 
too infrequently (reported on only 0.8% of the logs) to 
assess an association with recurrence. 
COMPARISON OF STRESS AND SYSTEMIC 
INFECTION REPORTING ON VALID AND 
INV AUD EXPOSURE WEEK LOGS 
For comparison purposes, we also examined the 26 recur-
rences excluded because the exposure week log was com-
pleted after the onset of symptoms of a recurrence. The base-
line characteristics of the 26 participants with an invalid re-
currence were similar to those of the 33 participants with 
a valid recurrence. Analyses revealed that both high glob-
al stress and systemic illness were reported more frequently 
on exposure week logs completed late after the onset of symp-
toms of the HSY recurrence than on logs completed prop-
erly before the onset of symptoms. High stress was reported 
on none of the 33 valid exposure week logs ( with nonmiss-
ing stress scores) and on 4 ( 16%) of the 25 invalid logs with 
a stress score (P = .03, Fisher exact test). Systemic illness was 
reported on 3 (9%) of the 35 valid logs and on 10 (38%) of 
the 26 invalid logs (P= .01, Fisher exact test). 
When the discrete-time proportional hazards model 
analysis was conducted using only the 26 recurrences in 
which the exposure week log was completed after symp-
tom onset, the computed rate ratios differed considerably 
from those estimated for the valid recurrences, showing a 
strong association between systemic infection and a re-
currence (rate ratio, 4.14; 95% confidence interval, 1.88-
9.15; P<.001) and suggesting a possible association be-
tween high stress and a recurrence (rate ratio for high stress 
compared with moderate or low stress, 2.04; 95% confi-
dence interval, 0.70-5.95; P=.19). Analyses conducted by 
the case-crossover method gave similar results (rate ratio 
Table 3. Cohort Analysis of the Association of Psychological Stress and Ocular HSV Recurrence in the 308 Participants* 







No. of Weeks 
With Logs for 
All Patients 
Weekly Global Stress 
Change From 
Average Global Stress 
With Recurrences‡ Unadjusted§ Adjusted§II Unadjusted¶ Adjusted§# 



























* HSV indicates herpes simplex virus; Cl, confidence interval; and ellipses, data not applicable. 
† Low indicates a stress rating of 1 to 2; moderate, 3 to 5; and high, 6 to 7.  
‡Distribution of global stress scores in exposure week for the 33 patients with a "valid" recurrence and a reported stress score (stress score missing for 
2 patients). 
§From a person-time formulation of a discrete-time proportional hazards model, with the global stress scores modeled as dummy variables. The adjusted 
model included age, sex, ethnicity (white and Asian vs African American and Hispanic), number of past ocular HSV episodes, negative affectivity (Taylor Manifest 
Anxiety Scale), social desirability (Marlowe-Crowne Social Desirability Scale), living situation (alone vs with others [missing recoded as with others]), acyclovir 
treatment group, self-reported illness, and study time. 
Iǁ One hundred sixty-six logs (including 2 recurrences) were not included in the analysis because of missing covariate data. 
¶Eighty-four logs (including 4 recurrences) were not included in the analysis because of missing data on average global stress during follow-up. 
# Two hundred fifty logs (including 6 recurrences) were not included in the analysis because of missing covariate data. 
* *  From a model with global stress score as a 3-level continuous variable. 
Table 4. Case-Crossover Analysis of the Association 
of Psychological Stress and Ocular HSV Recurrence 





















* HSV indicates herpes simplex virus; Cl, confidence interval; and ellipses, 
data not applicable. 
†Low indicates a stress rating of 1 to 2; moderate, 3 to 5; and high, 6 to 7. 
‡Distribution of global stress scores in exposure week for the 33 patients 
with a recurrence and a reported stress score on a valid exposure week log 
(stress score missing for 2 patients). 
§From a model including exposure week stress as a 3-level continuous 
variable. 
for systemic infection, 5.08; 95% confidence interval, 1.94-
13.30; P<.001; and rate ratio for high stress, 3.52; 95% 
confidence interval, 0.69-17.92; P=.13). 
When the 26 invalid recurrences were included in 
an analysis with the 33 valid recurrences, the unad-
justed rate ratio for the 3-level global stress variable was 
0.77 (95% confidence interval, 0.50-1.17; P=.22); for sys-
temic infection, it was 1.80 (95% confidence interval, 0.97-
3.33; P=.06). 
1n this prospective cohort study, we found no associa-
tion between high psychological stress or a change in psy-
chological stress and a recurrence of HSV infections in 
the eye. We also found no clear association of a recur-
rence with systemic infection or with sunlight expo-
sure. However, we did find that considerable bias would 
have been present in the estimate of the exposure-
disease association for systemic infection had we not lim-
ited our primary analysis to those recurrences in which 
the time-order relationship between exposure reporting 
and symptom onset was preserved. 
We can state with reasonable certainty that high 
stress is unlikely to be associated with the activation of 
HSV eye disease. Even if an association exists but was 
not identified in our study, the relationship is almost cer-
tainly weak. The upper limit of the 95% confidence in-
terval extends to 1.05, indicating that if our study is un-
biased, a true association is unlikely to have a rate ratio 
of a clinically meaningful magnitude that is appreciably 
greater than 1.0. 
Among the participants who developed an ocular 
HSV recurrence, none reported high stress on a valid 
exposure week log, and recurrences occurred more of-
ten in those reporting low stress during the exposure 
week (observed rate ratio, 0.58). Although this sugges-
tion of an association between low stress and an in-
creased incidence of recurrences is probably due to 
chance, another possible explanation could be that 
those reporting low stress levels were individuals who 
deny feeling stressed in stressful circumstances, even 
though physiologically they are having a strong stress 
response. 37 However, after categorizing the subjects 
into repressors (low anxiety and high social desirabil-
ity), sensitizers (high anxiety), and those thought to be 
"truly low anxious" (low anxiety and low social desir-
ability) using a method based on one previously de-
scribed, 38-40 we found that the participants reporting 
low stress in the exposure week of a recurrence in-
cluded fairly equal numbers of all 3 defensive style 
groups (35% repressor, 29% sensitizer, and 35% true 
low anxious), arguing against this possible explanation. 
Strengths of our study include a large sample size, pro-
spective data collection ( which provides evidence for time 
order and limits the possibility of recall bias), weekly ex-
Table 5. Cohort Analysis of the Association of Other Variables and Ocular HSV Recurrence in the 308 Participants* 
Exposure Reported 
on Weekly Log 
Exposure Week 





Sun exposure, h 
≤21 31 
>21 4 
Contact lens use§ 
No 28 
Yes 4 
No. of Weeks 




















* HSV indicates herpes simplex virus; Cl, confidence interval. 
†Distribution of variables in exposure week for patients with a recurrence and a valid exposure week log. 
‡Unadjusted rate ratio from univariate discrete-time proportional hazards models. 
§Exposure week data missing for 3 participants. 
posure measurement (which reduces exposure misclas-
sification among time-varying exposures), and physician 
confirmation of recurrence (which reduces outcome 
misclassification). However, even with the extensive ef-
forts we undertook to try to assure compliance with the 
protocol, many logs were completed late. For most weeks, 
completing the log a few days late did not pose a prob-
lem. However, for recurrences, even a few days delay in 
completing the log from the week covering the exposure 
period could mean that the exposure data were not re-
corded until after symptoms of the recurrence had be-
gun. Our results strongly indicate that both high stress and 
systemic infection, particularly the latter, were overre-
ported when logs were completed after symptoms of a re-
currence appeared. We found no evidence to indicate that 
having a systemic illness or high stress level might have 
been the reason a log was completed late; logs reporting 
one of these occurrences during nonexposure weeks were 
no more likely to be late than other logs (data not shown). 
If we had not excluded recurrences in which this time or-
der was violated, we could have erroneously concluded 
that systemic infection was associated with a recurrence. 
Exclusion of these recurrences, which was necessary to 
minimize bias, had the unwanted but unavoidable effect 
of reducing the power of the study. 
Our finding that psychological stress did not in-
crease the risk of a recurrence was consistent in all mod-
els that were assessed with both the discrete-time propor-
tional hazards model and case-crossover methods and when 
alternate measures of stress were evaluated, including the 
maximum stress reported on the Life Arenas Stress Mea-
sure on a weekly log, reporting of chronic stress on a weekly 
log, and a participant's average global stress across all logs. 
There was no evidence of confounding being present. De-
spite this consistency, consideration must be given to 
whether the measure of stress we used was reliable and 
valid for our purposes and to whether the exposure pe-
riod we assessed was appropriate. 
Although the global stress score we used has not been 
formally validated, other similar scales have been vali-
dated. Using similar single-item global measures of psy-
chological stress, Watson41 provided estimates of reli-
ability (Pearson r = 0. 71) and construct validity by 
correlation with a measure of negative emotion (Pear-
son r=0.44), and Cohen and Williamson42 reported a cor-
relation of 0.39 with the Perceived Stress Scale among 
disease-free adult subjects. 
Even with the intensive weekly data collection that 
resulted in the submission of 12236 logs by the 308 par-
ticipants, the data collection may have been too infre-
quent for optimal assessment of the stress-disease rela-
tionship. Little is known about the timing of this 
relationship. We a priori selected the exposure week for 
the stress assessment such that it fully preceded the onset 
of symptoms of a recurrence of HSY eye disease. Depend-
ing on the day of the week that the symptoms started, the 
7 -day period for exposure could have been as long as 7 to 
13 days before symptom onset or as short as 1 to 7 days 
before symptom onset. Thus, the measured exposure pe-
riod may not have included the critical exposure period (the 
period before the induction period during which stress 
could have a causal effect on recurrence). It is also pos-
sible that the critical exposure period is less than 7 days 
and, thus, the measured exposure period included back-
ground information irrelevant to the stress-disease rela-
tionship. We evaluated exposure periods 2 and 3 weeks 
before symptom onset and again found no association be-
tween high stress and a recurrence (data not shown). 
An additional potential source of error is lack of pre-
cision in determining the symptom-onset date. We used 
the weekly logs and the examination records to increase 
the accuracy of this determination. However, in some 
cases, the symptom-onset date was not available and 
needed to be imputed based on the date of examination 
documentation of the recurrence. In these cases and po-
tentially others, it is possible that inaccuracies in the symp-
tom-onset date could result in selection of the wrong ex-
posure week log for analysis. This would tend to bias away 
from detecting true exposure-disease associations. 
To our knowledge, there is no prior study of the as-
sociation of stress and ocular HSY recurrences for com-
parison with our results. Several studies have assessed the 
association between stress and nonocular HSY recur-
rences. No consistent finding has been reported. Prospec-
tive studies by Kemeny et al,43 Hoon et al, 18 and Rand et 
al44 found no clear association between psychological stress 
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and recurrence of genital herpes via monthly, weekly, and 
daily exposure assessment, respectively. Cohen et al, 19 us-
ing weekly stress assessment in a prospective study, found 
that persistent but not acute stress was associated with in-
creased genital herpes recurrence. Goldmeier et al 12 ex-
amined the time to first recurrence in patients in whom 
genital herpes was newly diag n osed and found that the Gen-
eral Health Questionnaire (a measure of psychiatric symp-
toms) was associated with an increased recurrence rate (rate 
ratio [10-U increase in the General Health Questionnaire 
score], 1.27; P<.02), but found no evidence of an asso-
ciation with a measure of stressful life events. Schmidt et 
al 16 found an increase in stressful life events and hassles 
during the week before an oral herpes recurrence com-
pared with a dormant week; however, stress was assessed 
after symptoms began (ie, within 3 days of the onset of 
the vesicular eruption). Padgett and colleagues,45 in a study 
of recurrence ofHSV-1-associated keratitis in mice, found 
that only 1 type of stress paradigm (social stress, not re-
straint stress) led to recrudescence in these animals. How-
ever, the biological mechanisms underlying reactivation 
and recrudescence could not be determined and are thought 
to be complex.43 
Our assessments of eye injury, contact lens wear, and 
the onset of a menstrual cycle were of insufficient power 
for any meaningful conclusions. For systemic infection and 
sunlight exposure, interpretation of the study results is lim-
ited by imprecise measurement of the exposure. 
Early experimental results of induced fever suggest 
a 24-hour induction period before the onset of orofacial 
herpes symptoms.5 In view of the potential that this criti-
cal exposure period was obscured or missed in our mea-
sured exposure period, we may have missed a true asso-
ciation between a systemic infection and the development 
of an ocular HSV recurrence. 
The literature7 suggests that an intense, short, UV light 
exposure may trigger HSV recurrence. Experimental UV 
light exposure among patients with orofaciaF or genital8 
herpes has shown an average induction period of 4 days. 
Although our data suggest the possibility of an associa-
tion of extensive sunlight exposure and HSV eye disease, 
in retrospect, our measure of sunlight exposure was in-
adequate. Assuming a 4-day or shorter induction period 
for our participants whose symptoms began on Friday and 
continued through Sunday (assuming log completion on 
the previous Sunday), the critical exposure period would 
not have been included in the weekly log designated as 
the measured exposure period. Furthermore, our study as-
sessed weekly sun exposure rather than intense episodes 
of sunlight exposure and, therefore, our measure was in-
sensitive to single intense exposures of short duration that 
could be sufficient to trigger a recurrence. 
High psychological stress does not appear to be a trigger 
of recurrences of HSV eye disease. Although our results 
suggest either that low stress may be associated with an 
increased risk of a recurrence or that high stress may be 
associated with a decreased risk, this finding is not sup-
ported by previous studies of oral and genital herpes re-
currences. Without a credible mechanism for this and rep-
lication in other studies, this association should not be 
accepted as plausible. Our finding of a strong potential 
bias toward overreporting of systemic infection and high 
stress when there was violation of the time-order require-
ments (for exposure reporting before symptom onset) 
makes suspect the results of HSV risk factor studies in 
which this time-order is not clearly established. If not ac-
counted for, recall bias can substantially overestimate the 
importance of  factors that do not have a causal associa-
tion with HSV infection. 
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